Related Experiment Video
Updated: Aug 8, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Antidepressants: general practitioners' opinions and clinical practice
S Rambelomanana1, F Depont, K Forest
1INSERM U657, Bordeaux, France.
Acta Psychiatrica Scandinavica
|May 9, 2006
Summary
General practitioners
Area of Science:
- Psychiatry and Mental Health
- Pharmacology
- General Practice
Background:
- Antidepressant prescribing patterns are influenced by various factors.
- Understanding general practitioners' (GPs) perspectives on antidepressant medications is crucial for optimizing depression treatment.
- Previous research has explored prescribing habits, but the link between GP opinion and actual drug performance requires further investigation.
Purpose of the Study:
- To compare French general practitioners' (GPs) opinions on antidepressant drugs with their actual prescription patterns.
- To analyze the relationship between GPs' perceived efficacy and tolerability of antidepressants and their clinical use.
- To investigate whether prescriber opinions align with objective measures of antidepressant performance, such as treatment discontinuation rates.
Main Methods:
- A representative sample of 181 French general practitioners (GPs) participated.
- GPs provided opinions on the 15 most prescribed antidepressants regarding efficacy and tolerability.
- GPs also described treatment details for 778 depressive patients, including drug changes and reasons.
Main Results:
- Paroxetine, fluoxetine, sertraline, and clomipramine were ranked highest for efficacy by GPs.
- Paroxetine, tianeptine, sertraline, and fluoxetine were rated highest for tolerability.
- Prescription patterns showed fluoxetine, paroxetine, and sertraline as most frequently prescribed.
- Discontinuation rates due to intolerance or inefficacy did not correlate with GPs' opinions on drug performance.
Conclusions:
- General practitioners' opinions on antidepressant efficacy and tolerability do not appear to be directly related to how these drugs perform in clinical practice.
- The study highlights a potential disconnect between subjective prescriber perceptions and objective patient outcomes in antidepressant therapy.
- Further research is needed to understand the factors influencing antidepressant prescription beyond perceived drug characteristics.
Related Concept Videos
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:54The Placebo Effect
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.